A Comprehensive Review on Moringa oleifera and Citrus limon for the Management of Rheumatoid Arthritis

Rheumatoid arthritis is a painful, long-term autoimmune disease where the body's immune system attacks its own joints, causing inflammation, cartilage breakdown, and deformity. Current pharmaceutical treatments — including drugs called DMARDs and biologics — can be effective but carry serious side effects and are often expensive, leaving many patients searching for safer options. This review examined the scientific literature on two plants, Moringa oleifera and lemon (Citrus limon), to assess whether their natural chemical compounds might offer relief for rheumatoid arthritis sufferers. Both plants contain a range of bioactive molecules — including flavonoids (plant pigments with anti-inflammatory effects), phenolic acids, terpenoids, and vitamins — that laboratory and animal studies suggest can reduce inflammation, counter oxidative stress (cellular damage from unstable molecules), and dampen the overactive immune responses that drive joint destruction. Specific compounds identified include quercetin and kaempferol from moringa, and hesperidin and d-limonene from lemon. The review also looked at how these compounds are being packaged — as extracts, essential oils, and nanoparticle delivery systems designed to improve how well the body absorbs and uses them. The authors conclude that these two plants show genuine promise as add-on or alternative therapies, but stress that human clinical trials are still largely absent. Without that evidence, the findings remain preliminary. The review calls for more rigorous mechanistic research and properly designed clinical studies before these plants can be confidently recommended as part of standard rheumatoid arthritis care.